Oscar Health (NYSE:OSCR) reported quarterly earnings of $1.10 per share which beat the analyst consensus estimate of $0.49 by 120 percent. This is a 223.6 percent increase over losses of $(0.89) per share from the same period last year. The company reported quarterly sales of $4.882 billion which beat the analyst consensus estimate of $4.751 billion by 2.77 percent. This is a 70.46 percent increase over sales of $2.864 billion the same period last year.